Biomarkers in amyotrophic lateral sclerosis: current status and future prospects

Disease heterogeneity in amyotrophic lateral sclerosis poses a substantial challenge in drug development. Categorization based on clinical features alone can help us predict the disease course and survival, but quantitative measures are also needed that can enhance the sensitivity of the clinical ca...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nature reviews. Neurology 2023-12, Vol.19 (12), p.754-768
Hauptverfasser:	McMackin, Roisin, Bede, Peter, Ingre, Caroline, Malaspina, Andrea, Hardiman, Orla
Format:	Artikel
Sprache:	eng
Schlagworte:	692/53 692/617/375/1917/1285 Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - diagnosis Biomarkers Disease Progression Drug Development Humans Medicin och hälsovetenskap Medicine Medicine & Public Health Neurology Pharmacodynamics Prognosis Review Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!